Travel Medicine and Infectious Disease
Volume 9, Issue 4 , Pages 176-186 , July 2011

Legionella infections and travel associated legionellosis

  • Cyril Guyard

      Affiliations

    • Ontario Agency for Health Protection and Promotion (OAHPP), 81 resources Road, Toronto, Ontario, M9P 3T1, Canada
    • Department of Laboratory Medicine & Pathobiology, University of Toronto, Medical Sciences Buildings, 1 King’s College Circle, 6th Floor, Toronto, Ontario, M5S 1A8, Canada
    • Mount Sinai Hospital, Toronto, Joseph and Wolf Lebovic Health Complex, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada
    • Corresponding Author InformationCorresponding author. Ontario Agency for Health Protection and Promotion (OAHPP), 81 Resources Road, Toronto, Ontario, M9P 3T1, Canada. Tel.: +1 416 235 5920; fax: +1 416 235 6281.
    • ,
  • Donald E. Low

      Affiliations

    • Ontario Agency for Health Protection and Promotion (OAHPP), 81 resources Road, Toronto, Ontario, M9P 3T1, Canada
    • Department of Laboratory Medicine & Pathobiology, University of Toronto, Medical Sciences Buildings, 1 King’s College Circle, 6th Floor, Toronto, Ontario, M5S 1A8, Canada
    • Mount Sinai Hospital, Toronto, Joseph and Wolf Lebovic Health Complex, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada

Received 11 May 2010 ,Accepted 17 May 2010.

References 

  1. Winn WC. Legionnaires disease: historical perspective. Clinical Microbiology Reviews. 1988;1:60–81
  2. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clinical Microbiology Reviews. 2002;15:506–526
  3. Luck CP, Jacobs E, Roske I, Schroter-Bobsin U, Dumke R, Gronow S. Legionella dresdenensis sp. nov. isolated from the river Elbe near Dresden in Germany. International Journal of Systematic and Evolutionary Microbiology. 2009;[Epub ahead of print]
  4. Fliermans CB, Cherry WB, Orrison LH, Smith SJ, Tison DL, Pope DH. Ecological distribution of Legionella pneumophila. Applied and Environmental Microbiology. 1981;41:9–16
  5. Speers DJ, Tribe AE. Legionella longbeachae pneumonia associated with potting mix. The Medical Journal of Australia. 1994;161:509
  6. Bhopal RS, Fallon RJ, Buist EC, Black RJ, Urquhart JD. Proximity of the home to a cooling tower and risk of non-outbreak Legionnaires’ disease. BMJ. 1991;302:378–383
  7. Taylor M, Ross K, Bentham R. Legionella, protozoa and biofilms: interactions within complex microbial systems. Microbial Ecology. 2009;58:538–547
  8. Atlas RM. Legionella: from environmental habitats to disease pathology, detection and control. Environmental Microbiology. 1999;1:283–293
  9. Atlas RM, Williams JF, Huntington MK. Legionella contamination of dental-unit waters. Applied and Environmental Microbiology. 1995;61:1208–1213
  10. Bollin GE, Plouffe JF, Para MF, Hackman B. Aerosols containing Legionella pneumophila generated by shower heads and hot-water faucets. Applied and Environmental Microbiology. 1985;50:1128–1131
  11. Bollin GE, Plouffe JF, Para MF, Prior RB. Difference in virulence of environmental isolates of Legionella pneumophila. Journal of Clinical Microbiology. 1985;21:674–677
  12. Mashiba K, Hamamoto T, Torikai K. A case of Legionnaires’ disease due to aspiration of hot spring water and isolation of Legionella pneumophila from hot spring water. Kansenshogaku Zasshi. 1993;67:163–166
  13. Cabanes PA, Dubrou S, Larguier M, Saude I, Festy B. Les Legionella dans l’environnement hydrique sanitaire: Données préliminaires pour une évaluation du risque en France. Medecine et maladies infectieuses. 1995;25:850–857
  14. Katz SM, Hammel JM. The effect of drying, heat, and pH on the survival of Legionella pneumophila. Annals of Clinical and Laboratory Science. 1987;17:150–156
  15. Murga R, Forster TS, Brown E, Pruckler JM, Fields BS, Donlan RM. Role of biofilms in the survival of Legionella pneumophila in a model potable-water system. Microbiology (Reading, England). 2001;147:3121–3126
  16. Declerck P, Behets J, Margineanu A, van Hoef V, De Keersmaecker B, Ollevier F. Replication of Legionella pneumophila in biofilms of water distribution pipes. Microbiological Research. 2007;
  17. Declerck P. Biofilms: the environmental playground of Legionella pneumophila. Environmental Microbiology. 2009;
  18. Donlan RM, Forster T, Murga R, et al. Legionella pneumophila associated with the protozoan Hartmannella vermiformis in a model multi-species biofilm has reduced susceptibility to disinfectants. Biofouling. 2005;21:1–7
  19. Rowbotham TJ. Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. Journal of Clinical Pathology. 1980;33:1179–1183
  20. Wadowsky RM, Butler LJ, Cook MK, et al. Growth-supporting activity for Legionella pneumophila in tap water cultures and implication of hartmannellid amoebae as growth factors. Applied and Environmental Microbiology. 1988;54:2677–2682
  21. Storey MV, Winiecka-Krusnell J, Ashbolt NJ, Stenstrom TA. The efficacy of heat and chlorine treatment against thermotolerant Acanthamoebae and Legionellae. Scandinavian Journal of Infectious Diseases. 2004;36:656–662
  22. Cirillo JD, Falkow S, Tompkins LS. Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion. Infection and Immunity. 1994;62:3254–3261
  23. Mody CH, Paine R, Shahrabadi MS, et al. Legionella pneumophila replicates within rat alveolar epithelial cells. The Journal of Infectious Diseases. 1993;167:1138–1145
  24. Horwitz MA. Formation of a novel phagosome by the Legionnaires’ disease bacterium (Legionella pneumophila) in human monocytes. The Journal of Experimental Medicine. 1983;158:1319–1331
  25. Chiaraviglio L, Brown DA, Kirby JE. Infection of cultured human endothelial cells by Legionella pneumophila. PLoS ONE. 2008;3:e2012
  26. Costa J, da Costa MS, Verissimo A. Colonization of a therapeutic spa with Legionella spp: a public health issue. Research in Microbiology;161:18–25.
  27. Ito I, Naito J, Kadowaki S, et al. Hot spring bath and Legionella pneumonia: an association confirmed by genomic identification. Internal Medicine (Tokyo, Japan). 2002;41:859–863
  28. Kuroki T, Ishihara T, Ito K, Kura F. Bathwater-associated cases of legionellosis in Japan, with a special focus on Legionella concentrations in water. Japanese Journal of Infectious Diseases. 2009;62:201–205
  29. Ruehlemann SA, Crawford GR. Panic in the potting shed. The association between Legionella longbeachae serogroup 1 and potting soils in Australia. The Medical Journal of Australia. 1996;164:36–38
  30. Cramp GJ, Harte D, Douglas NM, Graham F, Schousboe M, Sykes K. An outbreak of Pontiac fever due to Legionella longbeachae serogroup 2 found in potting mix in a horticultural nursery in New Zealand. Epidemiology and Infection;138:15–20.
  31. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires’ disease: description of an epidemic of pneumonia. The New England Journal of Medicine. 1977;297:1189–1197
  32. Glick TH, Gregg MB, Berman B, Mallison G, Rhodes WW, Kassanoff I. Pontiac fever. An epidemic of unknown etiology in a health department: I. Clinical and epidemiologic aspects. American Journal of Epidemiology. 1978;107:149–160
  33. Kaufmann AF, McDade JE, Patton CM, et al. Pontiac fever: isolation of the etiologic agent (Legionella pneumophila) and demonstration of its mode of transmission. American Journal of Epidemiology. 1981;114:337–347
  34. von Baum H, Ewig S, Marre R, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clinical Infectious Disease. 2008;46:1356–1364
  35. Vergis EN, Akbas E, Yu VL. Legionella as a cause of severe pneumonia. Seminars in Respiratory and Critical Care Medicine. 2000;21:295–304
  36. Smith P, Moore M, Alexander N, Hicks L, O’Loughlin R. Surveillance for travel-associated legionnaires disease–United States, 2005–2006. Mmwr. 2007;56:1261–1263
  37. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality. Archives of Internal Medicine. 1994;154:2417–2422
  38. Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires’ disease. The Journal of Experimental Medicine. 2003;198:1563–1572
  39. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires’ disease. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:2487–2489
  40. Ginevra C, Duclos A, Vanhems P, et al. Host-related risk factors and clinical features of community-acquired legionnaires disease due to the Paris and Lorraine endemic strains, 1998–2007, France. Clinical Infectious Disease. 2009;49:184–191
  41. Yu VL, Plouffe JF, Pastoris MC, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. The Journal of Infectious Diseases. 2002;186:127–128
  42. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR. Legionnaires’ disease: isolation of a bacterium and demonstration of its role in other respiratory disease. The New England Journal of Medicine. 1977;297:1197–1203
  43. Joseph CA, Ricketts KD. Legionnaires disease in Europe 2007–2008. Euro surveillance. 1949;15(3):
  44. Joseph CA. Legionnaires’ disease in Europe 2000–2002. Epidemiology and Infection. 2004;132:417–424
  45. Legionnaires’ disease in Europe, 1996. Bull World Health Organ. 1998;76:213–217
  46. Legionnaires’ disease in Europe, 1997. Relevé Épidémiologique Hebdomadaire. 1998;73:257–261
  47. Ricketts KD, Joseph CA. Legionnaires disease in Europe: 2005–2006. Euro surveillance. 2007;12:E7–E8
  48. Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-based pneumonia incidence study group. Archives of Internal Medicine. 1997;157:1709–1718
  49. Neil K, Berkelman R. Increasing incidence of legionellosis in the United States, 1990–2005: changing epidemiologic trends. Clinical Infectious Disease. 2008;47:591–599
  50. Hall-Baker PA, Nieves E, Jajosky RA, et al. Summary of notifiable diseases–United States, 2007. Mmwr. 2009;56:1–94
  51. Ng V, Tang P, Jamieson F, Guyard C, Low DE, Fisman DN. Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006. BMC Infectious Diseases. 2009;9:68
  52. Garcia-Fulgueiras A, Navarro C, Fenoll D, et al. Legionnaires’ disease outbreak in Murcia, Spain. Emerging Infectious Diseases. 2003;9:915–921
  53. Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980–1998: declining mortality and new patterns of diagnosis. Clinical Infectious Disease. 2002;35:1039–1046
  54. Dominguez A, Alvarez J, Sabria M, et al. Factors influencing the case-fatality rate of Legionnaires’ disease. The International Journal of Tuberculosis and Lung Disease. 2009;13:407–412
  55. Pedro-Botet ML, Yu VL. Treatment strategies for Legionella infection. Expert Opinion on Pharmacotherapy. 2009;10:1109–1121
  56. Plouffe JF, Breiman RF, Fields BS, et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clinical Infectious Disease. 2003;37:1475–1480
  57. Mykietiuk A, Carratala J, Fernandez-Sabe N, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clinical Infectious Disease. 2005;40:794–799
  58. Blazquez Garrido RM, Espinosa Parra FJ, Alemany Frances L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clinical Infectious Disease. 2005;40:800–806
  59. Sabria M, Pedro-Botet ML, Gomez J, et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest. 2005;128:1401–1405
  60. Blyth CC, Adams DN, Chen SC. Diagnostic and typing methods for investigating Legionella infection. N S W Public Health Bull. 2009;20:157–161
  61. Roig J, Aguilar X, Ruiz J, et al. Comparative study of Legionella pneumophila and other nosocomial-acquired pneumonias. Chest. 1991;99:344–350
  62. Edelstein PH, Beer KB, Sturge JC, Watson AJ, Goldstein LC. Clinical utility of a monoclonal direct fluorescent reagent specific for Legionella pneumophila: comparative study with other reagents. Journal of Clinical Microbiology. 1985;22:419–421
  63. Diederen BM. Legionella spp. and Legionnaires’ disease. The Journal of Infection. 2008;56:1–12
  64. Murdoch DR. Diagnosis of Legionella infection. Clinical Infectious Disease. 2003;36:64–69
  65. Burnsed LJ, Hicks LA, Smithee LM, et al. A large, travel-associated outbreak of legionellosis among hotel guests: utility of the urine antigen assay in confirming Pontiac fever. Clinical Infectious Disease. 2007;44:222–228
  66. Yzerman EP, den Boer JW, Lettinga KD, Schellekens J, Dankert J, Peeters M. Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires’ disease in The Netherlands. Journal of Clinical Microbiology. 2002;40:3232–3236
  67. Monforte R, Estruch R, Vidal J, Cervera R, Urbano-Marquez A. Delayed seroconversion in Legionnaire’s disease. Lancet. 1988;2:513
  68. Stolhaug A, Bergh K. Identification and differentiation of Legionella pneumophila and Legionella spp. with real-time PCR targeting the 16S rRNA gene and species identification by mip sequencing. Applied and Environmental Microbiology. 2006;72:6394–6398
  69. Reischl U, Linde HJ, Lehn N, Landt O, Barratt K, Wellinghausen N. Direct detection and differentiation of Legionella spp. and Legionella pneumophila in clinical specimens by dual-color real-time PCR and melting curve analysis. Journal of Clinical Microbiology. 2002;40:3814–3817
  70. Herpers BL, de Jongh BM, van der Zwaluw K, van Hannen EJ. Real-time PCR assay targets the 23S-5S spacer for direct detection and differentiation of Legionella spp. and Legionella pneumophila. Journal of Clinical Microbiology. 2003;41:4815–4816
  71. Templeton KE, Scheltinga SA, Sillekens P, et al. Development and clinical evaluation of an internally controlled, single-tube multiplex real-time PCR assay for detection of Legionella pneumophila and other Legionella species. Journal of Clinical Microbiology. 2003;41:4016–4021
  72. Yang G, Benson R, Pelish T, Brown E, Winchell JM, Fields B. Dual detection of Legionella pneumophila and Legionella species by real-time PCR targeting the 23S-5S rRNA gene spacer region. Clin Microbiol Infect;16:255–261.
  73. Diederen BM, de Jong CM, Marmouk F, Kluytmans JA, Peeters MF, Van der Zee A. Evaluation of real-time PCR for the early detection of Legionella pneumophila DNA in serum samples. Journal of Medical Microbiology. 2007;56:94–101
  74. Tijet N, Tang P, Romilowych M, et al. New endemic Legionella pneumophila serogroup I clones, Ontario, Canada Emerging Infectious Diseases;16:447–454.
  75. Feil EJ, Enright MC. Analyses of clonality and the evolution of bacterial pathogens. Current Opinion in Microbiology. 2004;7:308–313
  76. Para MF, Plouffe JF. Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6. Journal of Clinical Microbiology. 1983;18:895–900
  77. Tobin JO, Watkins ID, Woodhead S, Mitchell RG. Epidemiological studies using monoclonal antibodies to Legionella pneumophila serogroup 1. Israel Journal of Medical Sciences. 1986;22:711–714
  78. Watkins ID, Tobin JO, Dennis PJ, Brown W, Newnham R, Kurtz JB. Legionella pneumophila serogroup 1 subgrouping by monoclonal antibodies–an epidemiological tool. The Journal of Hygiene. 1985;95:211–216
  79. Joly JR, McKinney RM, Tobin JO, Bibb WF, Watkins ID, Ramsay D. Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies. Journal of Clinical Microbiology. 1986;23:768–771
  80. Fry NK, Alexiou-Daniel S, Bangsborg JM, et al. A multicenter evaluation of genotypic methods for the epidemiologic typing of Legionella pneumophila serogroup 1: results of a pan-European study. Clinical Microbiology and Infection. 1999;5:462–477
  81. Fry NK, Bangsborg JM, Bergmans A, et al. Designation of the European Working Group on Legionella Infection (EWGLI) amplified fragment length polymorphism types of Legionella pneumophila serogroup 1 and results of intercentre proficiency testing Using a standard protocol. European Journal of Clinical Microbiology and Infectious Diseases. 2002;21:722–728
  82. Ginevra C, Lopez M, Forey F, et al. Evaluation of a nested-PCR-derived sequence-based typing method applied directly to respiratory samples from patients with Legionnaires’ disease. Journal of Clinical Microbiology. 2009;47:981–987
  83. Gaia V, Fry NK, Afshar B, et al. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. Journal of Clinical Microbiology. 2005;43:2047–2052
  84. Pourcel C, Visca P, Afshar B, D’Arezzo S, Vergnaud G, Fry NK. Identification of variable-number tandem-repeat (VNTR) sequences in Legionella pneumophila and development of an optimized multiple-locus VNTR analysis typing scheme. Journal of Clinical Microbiology. 2007;45:1190–1199
  85. MLVA bank for Bacterial Genotyping . University of Orsay. [Accessed 29.04.2010], at http://minisatellites.u-psud.fr/MLVAnet/index.php
  86. Ratzow S, Gaia V, Helbig JH, Fry NK, Luck PC. Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains. Journal of Clinical Microbiology. 2007;45:1965–1968
  87. EWGLI Sequence-based typing (SBT) database for Legionella pneumophila. [Accessed 21/04/2010], at http://www.hpa-bioinformatics.org.uk/legionella/legionella_sbt/php/sbt_homepage.php2010;
  88. Scaturro M, Losardo M, De Ponte G, Ricci ML. Comparison of three molecular methods used for subtyping of Legionella pneumophila strains isolated during an epidemic of Legionellosis in Rome. Journal of Clinical Microbiology. 2005;43:5348–5350
  89. Afshar B, Fry NK, Bellamy W, Underwood AP, Harrison TG. External quality assessment of a DNA sequence-based scheme for epidemiological typing of Legionella pneumophila by an international network of laboratories. Journal of Clinical Microbiology. 2007;45:3251–3256
  90. Fry NK, Afshar B, Wewalka G, Harrison TG. Epidemiological typing of Legionella pneumophila in the absence of isolates. In:  Cianciotto NP,  Kwaik YA,  Edelstein PH editor. Legionella: state of the art 30 years after its recognition. Washington, DC: ASM Press; 2006;p. 152–155
  91. Luck PC, Ecker C, Reischl U, Linde HJ, Stempka R. Culture-independent identification of the source of an infection by direct amplification and sequencing of Legionella pneumophila DNA from a clinical specimen. Journal of Clinical Microbiology. 2007;45:3143–3144
  92. European guidelines for control and prevention of travel associated Legionnaires disease . [Accessed 21.04.2010], at http://www.ewgli.org/pdf_files/guidelinesjanuary2005.pdf2005;
  93. Mouchtouri V, Velonakis E, Tsakalof A, et al. Risk factors for contamination of hotel water distribution systems by Legionella species. Applied and Environmental Microbiology. 2007;73:1489–1492
  94. Bates MN, Maas E, Martin T, Harte D, Grubner M, Margolin T. Investigation of the prevalence of Legionella species in domestic hot water systems. The New Zealand Medical Journal. 2000;113:218–220
  95. Borella P, Montagna MT, Romano-Spica V, et al. Legionella infection risk from domestic hot water. Emerging Infectious Diseases. 2004;10:457–464
  96. Leoni E, De Luca G, Legnani PP, Sacchetti R, Stampi S, Zanetti F. Legionella waterline colonization: detection of Legionella species in domestic, hotel and hospital hot water systems. Journal of Applied Microbiology. 2005;98:373–379
  97. Rowbotham TJ. Legionellosis associated with ships: 1977 to 1997. Communicable Disease and Public Health. 1998;1:146–151
  98. Meenhorst PL, van der Meer JW, Borst J. Sporadic cases of Legionnaires’ disease in the Netherlands. Annals of Internal Medicine. 1979;90:529–532
  99. Kobayashi A, Yamamoto Y, Chou S, Hashimoto S. Severe Legionella pneumophila pneumonia associated with the public bath on a cruise ship in Japan. Journal of Anesthesia. 2004;18:129–131
  100. Christenson B, Lidin-Janson G, Kallings I. Outbreak of respiratory illness on board a ship cruising to ports in southern Europe and northern Africa. The Journal of Infection. 1987;14:247–254
  101. Jernigan DB, Hofmann J, Cetron MS, et al. Outbreak of Legionnaires’ disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet. 1996;347:494–499
  102. Rowbotham TJ. Isolation of Legionella pneumophila serogroup 1 from human feces with use of amebic cocultures. Clinical Infectious Diseases. 1998;26:502–503
  103. Castellani Pastoris M, Lo Monaco R, Goldoni P, et al. Legionnaires’ disease on a cruise ship linked to the water supply system: clinical and public health implications. Clinical Infectious Diseases. 1999;28:33–38
  104. Vessel Sanitation Program Operations Manual . [Accessed 21.04.2010], at http://www.cdc.gov/nceh/vsp/operationsmanual/OPSManual2005.pdf2005;
  105. Strengthening surveillance for travel-associated legionellosis and revised case definitions for legionellosis. [Accessed 21.04.2010], at http://www.cdc.gov/legionella/files/Legionella_CSTE_statement.pdf2005;
  106. Hutchinson EJ, Joseph C, Bartlett CL. EWGLI: a European surveillance scheme for travel associated legionnaires disease. Euro surveillance. 1996;1:37–39
  107. Ricketts KD, Yadav R, Joseph CA. Travel-associated Legionnaires disease in Europe: 2006. Euro surveillance. 2008;13:
  108. Alexander N, Hicks L. Travel-associated Legionnaires’Disease surveillance in the United states, 2005–2008. In: LEGIONELLA 2009; 2009 October 13–17. Paris, France: 2009 Institut Pasteur; 2009;p. 11
  109. Joseph CA, Yadav R, Ricketts KD. Travel-associated Legionnaires disease in Europe in 2007. Euro surveillance. 2009;14
  110. Rota MC, Cano Portero R, Che D, Caporali MG, Hernando V, Campese C. Clusters of travel-associated legionnaires disease in Italy, Spain and France, July 2002-June 2006. Euro surveillance. 2007;12:E3–E4
  111. EWGLI cases by Month of onset and year of onset. [Accessed 21.04.2010], at http://ecdc.europa.eu/en/activities/surveillance/ELDSNet/Pages/Monthly_reports.aspx2010;
  112. Hilbi H, Jarraud S, Hartland E, Buchrieser C. Update on Legionnaires’ disease: pathogenesis, epidemiology, detection and control. Molecular Microbiology. 2010;[Epub ahead of print]
  113. Bartram J, Chartier Y, Lee JV, Pond K, Surman-Lee S. 1–276 In: Organization WH  editors. Legionella and the prevention of legionellosis. Geneva: WHO Press; 2007;
  114. Barbaree JM, Gorman GW, Martin WT, Fields BS, Morrill WE. Protocol for sampling environmental sites for legionellae. Applied and Environmental Microbiology. 1987;53:1454–1458
  115. Procedures for collecting and processing environmental specimens for Legionella spp. [Accessed 21/04/2010], at http://www.cdc.gov/legionella/procedures.htm2009;

PII: S1477-8939(10)00071-2

doi: 10.1016/j.tmaid.2010.05.006

Travel Medicine and Infectious Disease
Volume 9, Issue 4 , Pages 176-186 , July 2011

Article Tools

* Image Usage & Resolution